Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Clotblog with Dr Samuel Goldhaber
View all posts »Coagulopathy from liver disease does not protect against VTE
Aug 16, 2010 09:35 EDT-
1Comments
-
Read later
In his recent paper, Dr Ousama Dabbagh shows that patients with advanced liver disease are at high risk of developing PE and DVT. The take-home message is important: don't be fooled by a high INR in a patient with liver disease, as it in no way implies protection from VTE.
What is your experience with VTE in liver disease patients?
See:
Dabbagh O, Oza A, Prakash S, et al. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest 2010;137: 1145-1149. Abstract.
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
